Aralez Pharmaceuticals Inc. — Form D

Aralez Pharmaceuticals Inc. of Vancouver, A1, a company, filed a Form D exempt-offering notice with the SEC on 2016-02-19. The offering totals $75.0M, of which $75.0M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2016-02-19
Form: D
Accession: 0001660719-16-000001
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $75.0M
Amount sold: $75.0M
Investors: 3
Date of first sale: 2016-02-05
Security types: debt
Revenue range: $25,000,001 - $100,000,000
SEC file number: 021-257798

Issuer

Name: Aralez Pharmaceuticals Inc.
CIK: 0001660719
Entity type: Corporation
Jurisdiction: BRITISH COLUMBIA, CANADA
Incorporated: 2015
Address: 2800 Park Place, 666 Burrard Street, Vancouver, A1, V6C 2Z7
Phone: 919-913-1030

Officers, directors & promoters (15)

Name	Role	Location
Adrian Adams	Director	Hayward, CA
Jason M Aryeh	Director	Greenwich, CT
NEAL F FOWLER	Director	MORRISVILLE, NC
Rob F Harris	Director	Vancouver, A1
Arthur S Kirsch	Director	Morrisville, NC
Kenneth B Lee Jr.	Director	Vancouver, A1
Seth A Rudnick, M.D.	Director	Vancouver, A1
F. Martin B Thrasher	Director	Vancouver, A1
Adrian Adams	Executive Officer	Hayward, CA
Jennifer L Armstrong	Executive Officer	Vancouver, A1
Scott J Charles	Executive Officer	Vancouver, A1
Mark A Glickman	Executive Officer	Cambridge, MA
Andrew I Koven	Executive Officer	Boston, MA
Eric L Trachtenberg	Executive Officer	Watertown, MA
James P Tursi, M.D.	Executive Officer	Vancouver, A1

More